Toth Financial Advisory’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.7K | Sell |
997
-4,629
| -82% | -$212K | 0.01% | 321 |
|
|
2025
Q1 | $271K | Sell |
5,626
-3,030
| -35% | -$146K | 0.03% | 194 |
|
|
2024
Q4 | $439K | Sell |
8,656
-2,799
| -24% | -$142K | 0.05% | 164 |
|
|
2024
Q3 | $730K | Sell |
11,455
-1,201
| -9% | -$76.6K | 0.09% | 144 |
|
|
2024
Q2 | $750K | Sell |
12,656
-13,455
| -52% | -$797K | 0.1% | 136 |
|
|
2024
Q1 | $1.5M | Buy |
26,111
+14,870
| +132% | +$856K | 0.19% | 106 |
|
|
2023
Q4 | $641K | Buy |
11,241
+1,655
| +17% | +$94.4K | 0.09% | 149 |
|
|
2023
Q3 | $460K | Sell |
9,586
-320
| -3% | -$15.4K | 0.07% | 153 |
|
|
2023
Q2 | $515K | Buy |
9,906
+815
| +9% | +$42.4K | 0.07% | 144 |
|
|
2023
Q1 | $493K | Sell |
9,091
-7,880
| -46% | -$427K | 0.08% | 150 |
|
|
2022
Q4 | $979K | Buy |
16,971
+9,440
| +125% | +$545K | 0.16% | 108 |
|
|
2022
Q3 | $359K | Sell |
7,531
-566
| -7% | -$27K | 0.07% | 149 |
|
|
2022
Q2 | $392K | Sell |
8,097
-1,550
| -16% | -$75K | 0.07% | 148 |
|
|
2022
Q1 | $598K | Sell |
9,647
-340
| -3% | -$21.1K | 0.09% | 150 |
|
|
2021
Q4 | $810K | Sell |
9,987
-11,223
| -53% | -$910K | 0.11% | 141 |
|
|
2021
Q3 | $2.01M | Buy |
21,210
+5,773
| +37% | +$548K | 0.31% | 88 |
|
|
2021
Q2 | $1.52M | Buy |
15,437
+5,215
| +51% | +$514K | 0.23% | 98 |
|
|
2021
Q1 | $855K | Sell |
10,222
-11,310
| -53% | -$946K | 0.14% | 117 |
|
|
2020
Q4 | $1.86M | Sell |
21,532
-25
| -0.1% | -$2.16K | 0.32% | 79 |
|
|
2020
Q3 | $1.51M | Sell |
21,557
-3,255
| -13% | -$228K | 0.29% | 83 |
|
|
2020
Q2 | $1.8M | Buy |
24,812
+6,395
| +35% | +$464K | 0.39% | 72 |
|
|
2020
Q1 | $852K | Buy |
18,417
+11,275
| +158% | +$522K | 0.25% | 83 |
|
|
2019
Q4 | $441K | Buy |
7,142
+512
| +8% | +$31.6K | 0.09% | 139 |
|
|
2019
Q3 | $282K | Sell |
6,630
-166
| -2% | -$7.06K | 0.06% | 146 |
|
|
2019
Q2 | $352K | Sell |
6,796
-2,705
| -28% | -$140K | 0.08% | 126 |
|
|
2019
Q1 | $527K | Buy |
9,501
+575
| +6% | +$31.9K | 0.12% | 106 |
|
|
2018
Q4 | $376K | Sell |
8,926
-19,107
| -68% | -$805K | 0.1% | 109 |
|
|
2018
Q3 | $1.95M | Buy |
28,033
+70
| +0.3% | +$4.88K | 0.43% | 69 |
|
|
2018
Q2 | $1.6M | Sell |
27,963
-310
| -1% | -$17.7K | 0.37% | 75 |
|
|
2018
Q1 | $1.56M | Buy |
28,273
+452
| +2% | +$24.9K | 0.38% | 74 |
|
|
2017
Q4 | $1.56M | Buy |
27,821
+10
| +0% | +$561 | 0.37% | 76 |
|
|
2017
Q3 | $1.7M | Buy |
27,811
+5,821
| +26% | +$356K | 0.43% | 71 |
|
|
2017
Q2 | $1.17M | Buy |
21,990
+22
| +0.1% | +$1.18K | 0.31% | 80 |
|
|
2017
Q1 | $1.06M | Buy |
+21,968
| New | +$1.06M | 0.28% | 84 |
|
|
2016
Q4 | – | Sell |
-16,310
| Closed | -$790K | – | 119 |
|
|
2016
Q3 | $790K | Buy |
+16,310
| New | +$790K | 0.23% | 91 |
|